Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models

Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models

Intraperitoneal (IP) chemotherapy for ovarian cancer treatment prolongs overall survival by 16 months compared to intravenous chemotherapy but is not widely practiced due to catheter-related complications and complexity of administration. An implantable, nonresorbable IP microdevice was used to rele...

Full description

Bibliographic Details
Main Authors:	Na, Young Jeong, Fulci, Giulia, del Carmen, Marcela G., Birrer, Michael J., Ye, Hongye, Tanenbaum, Laura Melanie, Mantzavinou, Aikaterini, Cima, Michael J.
Other Authors:	Harvard University--MIT Division of Health Sciences and Technology
Format:	Article
Language:	en_US
Published:	Elsevier 2017
Online Access:	http://hdl.handle.net/1721.1/106467 https://orcid.org/0000-0001-8586-6900 https://orcid.org/0000-0003-2379-6139

Similar Items

Sustained-release implants for intraperitoneal cisplatin delivery
by: Mantzavinou, Aikaterini
Published: (2019)

Design of an intraperitoneal drug-release device for advanced ovarian cancer therapy
by: Tanenbaum, Laura Melanie
Published: (2016)

An intraperitoneal implantable drug delivery device for the treatment of ovarian cancer
by: Ye, Hongye
Published: (2014)

Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
by: Shafiee MN,, et al.
Published: (2013)

Chemotherapy-Eluting Intraperitoneal Implants for Advanced Stage Ovarian Cancer Treatment
by: Subramanyam, Kriti S.
Published: (2022)

Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors
by: Chowanadisai, Winyoo, et al.
Published: (2016)

Design thinking in development engineering education: a case study on creating prosthetic and assistive technologies for the developing world
by: Ranger, Bryan J., et al.
Published: (2020)

Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model
by: Wood, Joseph, et al.
Published: (2016)

Immuno-pathophysiological responses of mouse model to experimental infection with Brucella melitensis and its lipopolysaccharides via intraperitoneal route
by: Osman, Abdinasir Yusuf, et al.
Published: (2016)

Single compartment drug delivery
by: Cima, Michael J., et al.
Published: (2016)

The nuage mediates retrotransposon silencing in mouse primordial ovarian follicles
by: Lim, Ai Khim, et al.
Published: (2016)

Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model
by: Jakobsen, Tim H., et al.
Published: (2013)

Layer‐by‐layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum‐based drug resistance therapy in ovarian cancer
by: Mensah, Lawrence B., et al.
Published: (2022)

Layer‐by‐layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum‐based drug resistance therapy in ovarian cancer
by: Mensah, Lawrence B, et al.
Published: (2021)

Delayed hypersensitivity reaction secondary to intraperitoneal vancomycin administration
by: Zakaria, NF, et al.
Published: (2023)

Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.
by: Shafee, Norazizah, et al.
Published: (2008)

Lethal dose, clinical signs, pathological changes and disease development of Streptococcus agalactiae following intraperitoneal exposure to Javanese medaka (Oryzias javanicus, Bleeker 1854)
by: Mastor, Siti Suhaiba
Published: (2018)

The Ligand Binding Domain of GCNF Is Not Required for Repression of Pluripotency Genes in Mouse Fetal Ovarian Germ Cells
by: Okumura, Leah M., et al.
Published: (2013)

Gastrointestinal: Massive intraperitoneal haemorrhage in a young woman with Hereditary Hemorrhagic telangiectasia
by: Sivarani, S., et al.
Published: (2010)

Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer
by: Oliver, Trudy, et al.
Published: (2011)

The Chemo-Sensitisation Effect Of Curcumin Against Low Dose Cisplatin On Non-Small Cell Lung Cancer (NSCLC) Stem Cells
by: Nazilah, Abdul Satar
Published: (2018)

Consequences of Cisplatin Binding on Nucleosome Structure and Dynamics
by: Todd, Ryan C., et al.
Published: (2015)

Binding Interaction of HMGB4 with Cisplatin-Modified DNA
by: Park, Semi, et al.
Published: (2013)

Acetate-Bridged Platinum(III) Complexes Derived from Cisplatin
by: Wilson, Justin J., et al.
Published: (2013)

The effects of intramuscular and intraperitoneal injections of benzo(a)pyrene on selected biomarkers in Clarias gariepinus.
by: Varnamkhasti, Ali Karami, et al.
Published: (2011)

Plasmonic Photothermal Heating of Intraperitoneal Tumors through the Use of an Implanted Near-Infrared Source
by: Bagley, Alexander F., et al.
Published: (2013)

Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
by: Lauffer, Sam, et al.
Published: (2018)

Mitaplatin, a Potent Fusion of Cisplatin and the Orphan Drug Dichloroacetate
by: Lippard, Stephen J., et al.
Published: (2011)

Machine-learning aided in situ drug sensitivity screening predicts treatment outcomes in ovarian PDX tumors
by: Cotler, Max J, et al.
Published: (2022)

Understanding and improving the anticancer activity of cisplatin
by: He, Qing, 1973-
Published: (2009)

Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
by: Lauffer, Sam, et al.
Published: (2018)

Development and characterization of a novel variable low-dose rate irradiator for in vivo mouse studies
by: Davidson, Matthew Allen, et al.
Published: (2010)

Ovarian haemangioma in sows
by: Sheikh Omar, Abdul Rahman, et al.
Published: (1985)

Redox State-Dependent Interaction of HMGB1 and Cisplatin-Modified DNA
by: Park, SeMi, et al.
Published: (2012)

The responses of cellular proteins to cisplatin-damaged DNA
by: Zamble, Deborah B. (Deborah Beth), 1971-
Published: (2012)

Mechanism-based rational design of cisplatin analogues
by: Barnes, Katie R., 1978-
Published: (2008)

The study of caseous lymphadenitis: dose dependent infection of C. pseudotuberculosis in mouse model via oral inoculation
by: Osman, Abdinasir Yusuf, et al.
Published: (2014)

Mucosal responses of brown-marbled grouper Epinephelus fuscoguttatus (Forsskl, 1775) following intraperitoneal infection with Vibrio harveyi
by: Cheng, Catherine Yun Chieng, et al.
Published: (2020)

Endogenously produced nitric oxide mitigates sensitivity of melanoma cells to cisplatin
by: Godoy, Luiz Claudio, et al.
Published: (2013)

Ovarian tissue characterization in ultrasound: A Review
by: Acharya, U.R., et al.
Published: (2015)